American Chapter · Part I · New York City
One year inside one of the world's foremost neurocognitive research environments — working directly under a global pioneer, at the absolute edge of what medicine understood about the aging brain.
In February 2005, I stepped off a plane into New York City and into the most intellectually demanding environment of my career — the Aging and Dementia Research Center of NYU Medical Center, housed within the historic Millhauser Laboratories of the Silberstein Alzheimer's Institute. What followed was a year that permanently reshaped how I think as a physician.
The Institution
The Aging and Dementia Research Center, based in the historic Millhauser Laboratories, was among the world's premier environments for neurocognitive research — operating at the intersection of clinical care, longitudinal patient study, and cutting-edge dementia science.
New York City Alzheimer's Research Clinical FellowshipThere are moments in a physician's career that divide everything into before and after. For me, arriving at NYU Medical Center in February 2005 was one of those moments.
Joining the Aging and Dementia Research Center as a Clinical Research Fellow meant stepping into an environment operating at the absolute frontier of global neurocognitive science. This was not a peripheral research posting — it was the Silberstein Alzheimer's Institute, housed in the historic Millhauser Laboratories, one of the most respected addresses in dementia research in the world.
The environment demanded everything. Patient volumes were immense, academic expectations were exacting, and the clinical questions being asked — about how the brain deteriorates, how that deterioration can be staged, measured, and one day interrupted — were among the most consequential in all of medicine. Arriving here from Karachi, I understood immediately that this fellowship would either make me or break me. It made me.
Professor of Psychiatry
NYU School of Medicine
Pioneer in Dementia Staging
Professor Barry Reisberg needs little introduction to anyone working in geriatric psychiatry or dementia research. His landmark work on dementia staging — the Global Deterioration Scale, the Brief Cognitive Rating Scale, the FAST scale — had already reshaped international clinical protocols and given the world a systematic language for understanding Alzheimer's disease progression long before I joined his team.
To serve as a fellow on his core team was to operate inside a living institution of neurocognitive science. Every case discussion, every patient encounter, every data review carried the intellectual weight of decades of foundational research. Dr. Reisberg's standard was exacting — precision in observation, rigour in documentation, and an absolute refusal to accept ambiguity in clinical assessment. Those standards became mine.
Beyond the research laboratory, I was entrusted to support Dr. Reisberg during his private patient consultations — conducted in a dedicated residential suite nearby — an arrangement that demanded clinical empathy, absolute discretion, and the ability to manage complex longitudinal patient relationships with seamless care.
The fellowship was not a comfortable academic rotation. Days began early and extended late — often into the night — driven by the volume of research protocols running simultaneously and the demands of a patient population that required meticulous longitudinal tracking. This was the kind of environment where sustained intellectual effort was simply the baseline expectation.
My responsibilities spanned both the research laboratory and direct patient care. Within the Millhauser Laboratories, I was embedded in the management of clinical research workflows — contributing to neurocognitive assessment protocols, tracking patient data across longitudinal studies, and supporting the operational demands of a high-output academic research programme. The methodology was rigorous: careful documentation, structured assessment instruments, and an emphasis on reproducibility that reflected the FDA-level standards the team operated under.
Dementia research teaches a particular kind of clinical patience — the understanding that the brain's story unfolds over years, not hours, and that only meticulous longitudinal observation can reveal what a single assessment never could.
Alongside the research work, I supported Dr. Reisberg in his private patient consultations. Managing these deeply personal, longitudinal clinical relationships — with patients and families navigating some of the most frightening diagnoses in medicine — demanded a level of care and communication that no textbook teaches. It was in these quieter, more intimate settings that the human dimension of neurocognitive disease became most vivid to me.
Research Environment
One of the most storied research addresses in American academic medicine — home to decades of foundational dementia science and the institutional base for Professor Reisberg's landmark longitudinal work.
Research Scope: Alzheimer's disease staging and progression, neurocognitive assessment methodology, longitudinal patient tracking, treatment trial protocols
Care Setting: Both public research infrastructure and private longitudinal patient consultations — requiring dual competency in research rigour and elite clinical empathy
What distinguished Dr. Reisberg's team was not simply the quality of individual expertise — it was the purposeful integration of disciplines under a single clinical banner. Neurologists, psychiatrists, internal medicine physicians, and research psychologists worked in genuine daily collaboration. The result was a clinical culture that taught something no single-specialty posting ever could.
Deep immersion in the mechanisms, staging, and clinical trajectory of Alzheimer's disease and related dementias — at a team that had helped define the field's global standards.
Structured assessment instruments, longitudinal data tracking, protocol compliance, and the discipline of rigorous clinical documentation that FDA-level research demands.
Daily exposure to how psychiatric symptoms — depression, agitation, psychosis — emerge from and interact with neurodegenerative processes in aging populations.
Supporting longitudinal consultations in a private clinical setting — developing the empathy, discretion, and communication depth that complex, high-stakes patient relationships require.
A fellowship at this level does not merely add skills to a CV — it restructures how a physician thinks. The clinical standards, research discipline, and interdisciplinary perspective absorbed at NYU became the lens through which every subsequent patient encounter was filtered.
Structured administration and interpretation of validated dementia assessment instruments — GDS, BCRS, MMSE, FAST staging — under the direct guidance of their originator.
Protocol development, participant tracking, data collection, and longitudinal case management within a rigorous academic research environment.
Advanced understanding of Alzheimer's pathophysiology, staging criteria, disease trajectory, and the therapeutic landscape as it existed at the research frontier.
The habit of approaching complex patients through multiple disciplinary lenses simultaneously — neurological, psychiatric, internal medicine — rather than any single specialty framework.
Working with patients and families managing devastating diagnoses — developing the clarity, empathy, and emotional composure that this context demands.
Exposure to the documentation rigour, ethical standards, and scientific methodology that characterise world-class academic medical research in the United States.
The year at NYU was not simply another line on a CV. It was a professional crucible — the environment where a physician from Karachi absorbed the clinical standards, research rigour, and intellectual discipline of one of the world's great academic medical institutions. The meticulous tracking, the structured longitudinal methodology, the interdisciplinary clinical philosophy — these did not stay in New York. They came back to Pakistan, and they have shaped every clinical decision, every patient interaction, and every research endeavour since. The Reisberg standard, once internalised, does not leave you.
The NYU fellowship was the first chapter of an American journey that continued westward. From New York, I moved to Charleston Area Medical Center (CAMC) and West Virginia University, where a second and very different research experience awaited — FDA-regulated pharmaceutical drug trials, GCP compliance, and the operational mechanics of industrial-scale clinical research. Together, the two American postings created a research foundation that no single fellowship could have provided: neurocognitive science at NYU, and regulatory trial methodology at CAMC.
Both chapters of the American journey are part of the same formative arc — a Pakistani physician immersing himself in the highest standards of American academic medicine, and bringing those standards home.
Each chapter is part of a broader career built across specialties, institutions, and two continents.